Form Type: 4

SEC EDGAR Link
Accession Number:0001140361-22-012919
Date:2022-03-31
Issuer: PYXIS ONCOLOGY, INC. (PYXS)
Original Submission Date:

Reporting Person:

CIVIK THOMAS
C/O PYXIS ONCOLOGY, INC.
35 CAMBRIDGEPARK DRIVE CAMBRIDGE, MA 02140

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
COMMON STOCK 2022-03-31 A 66,831 a $0.00 66,831 direct
COMMON STOCK 2022-03-31 0 $0.00 15,700 indirect
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
Footnotes
IDfootnote
f1 represents restricted stock units that vest 100% on the first anniversary of the grant date, subject to the reporting person's continued service through the applicable vesting date.
f2 these shares are held directly by the civik family trust, a revocable trust for which the reporting person and his spouse are the grantors.
WhaleWisdom Logo

Elevate your investments